CB

Christian Behrenbruch

Telix Pharmaceuticals Limited | Chief Executive Officer, Managing Director
Dr Behrenbruch has previously served as Chief Executive Officer at Mirada Solutions from July 2001 to December 2002, President at CTI Molecular Imaging (now Siemens Healthcare) from August 2003 to September 2006, Chief Executive Officer at Fibron Technologies, Inc. from June 2008 to December 2011 and Chief Executive Officer at ImaginAb, Inc from October 2007 to February 2015.

Company and Roles

Company
Title
Tenure
Since
TLX
TLX
Telix Pharmaceuticals Limited
  • Chief Executive Officer
  • Managing Director
9yrs, 5mthJan 2017

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
TLX
Telix Pharmaceuticals Limited
29/04/26654,00620,742,9350N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
TLX
Telix Pharmaceuticals Limited
29/04/26
Buy
67,935$14.671$996,699On-market trade
TLX
TLX
Telix Pharmaceuticals Limited
16/03/26
Expiry
20,045$10.980$220,094As advised by the company
TLX
TLX
Telix Pharmaceuticals Limited
05/11/25
Issued
100,708$4.380$441,101Exercise of options
TLX
TLX
Telix Pharmaceuticals Limited
05/11/25
Exercise
100,708$4.380$441,101Exercise of options
TLX
TLX
Telix Pharmaceuticals Limited
13/06/25
Issued
169,078$11.100$1,876,796Director remuneration